CanSino Biologics Inc. (HKG:6185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
29.84
-2.20 (-6.87%)
Apr 29, 2026, 4:08 PM HKT

CanSino Biologics Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
1,3292,0232,8223,4655,645
Upgrade
Short-Term Investments
326.32---275.2
Upgrade
Trading Asset Securities
987.971,1821,3082,4821,862
Upgrade
Cash & Short-Term Investments
2,6443,2044,1305,9477,783
Upgrade
Cash Growth
-17.50%-22.41%-30.55%-23.59%52.19%
Upgrade
Accounts Receivable
782.88737.62636.88855.49157.93
Upgrade
Other Receivables
43.4144.793.980.5419.15
Upgrade
Receivables
862.62818.73640.87856.03177.08
Upgrade
Inventory
347.85283.41352.85677.78875.62
Upgrade
Prepaid Expenses
--0.25--
Upgrade
Other Current Assets
-15.38-24.0357249.59454.49
Upgrade
Total Current Assets
3,8394,2825,1817,7309,290
Upgrade
Property, Plant & Equipment
2,6112,6413,0133,0692,218
Upgrade
Long-Term Investments
162.09483.71446.5650.1245.31
Upgrade
Other Intangible Assets
188.75115.49144.15220.92172.12
Upgrade
Long-Term Deferred Tax Assets
211.55205.39207.86196.41-
Upgrade
Long-Term Deferred Charges
137.93172.2188.451.9526.19
Upgrade
Other Long-Term Assets
27.3457.99237.53150.37122.42
Upgrade
Total Assets
7,1787,9589,31911,46911,874
Upgrade
Accounts Payable
50.4462.47103.97253.12842.57
Upgrade
Accrued Expenses
456.29400.08454.55407.25362.44
Upgrade
Short-Term Debt
73.22377.35883.971,530990.68
Upgrade
Current Portion of Long-Term Debt
245.31514.82509.1745.7790.11
Upgrade
Current Portion of Leases
5.439.9964.6348.7631.18
Upgrade
Current Income Taxes Payable
5.124.660.54329.14
Upgrade
Current Unearned Revenue
18.2314.693.571.48193.22
Upgrade
Other Current Liabilities
190.98302.68544.9635.52322.08
Upgrade
Total Current Liabilities
1,0451,6872,5652,9252,861
Upgrade
Long-Term Debt
956.951,0991,066878.0140
Upgrade
Long-Term Leases
7.6212.68175.18198.29222.85
Upgrade
Long-Term Unearned Revenue
214.38250.3216.72222.35201.48
Upgrade
Long-Term Deferred Tax Liabilities
----0.56
Upgrade
Other Long-Term Liabilities
--8.49--
Upgrade
Total Liabilities
2,2243,0484,0314,2233,326
Upgrade
Common Stock
247.04247.45247.45247.45247.45
Upgrade
Additional Paid-In Capital
5,1656,5776,5746,6086,598
Upgrade
Retained Earnings
-459.08-1,819-1,44042.711,150
Upgrade
Treasury Stock
--95.62-106.17-150.17-
Upgrade
Comprehensive Income & Other
0.190.22-0.180.12-
Upgrade
Total Common Equity
4,9544,9105,2756,7487,995
Upgrade
Minority Interest
--12.81497.51552.84
Upgrade
Shareholders' Equity
4,9544,9105,2877,2468,548
Upgrade
Total Liabilities & Equity
7,1787,9589,31911,46911,874
Upgrade
Total Debt
1,2892,0132,6992,7011,375
Upgrade
Net Cash (Debt)
1,3551,1911,4313,2466,408
Upgrade
Net Cash Growth
13.79%-16.79%-55.91%-49.34%28.90%
Upgrade
Net Cash Per Share
5.354.815.8013.1425.91
Upgrade
Filing Date Shares Outstanding
247.04249.18247.04246.77247.45
Upgrade
Total Common Shares Outstanding
247.04249.18247.04246.77247.45
Upgrade
Working Capital
2,7942,5962,6164,8056,428
Upgrade
Book Value Per Share
20.0519.7021.3527.3532.31
Upgrade
Tangible Book Value
4,7654,7945,1306,5277,823
Upgrade
Tangible Book Value Per Share
19.2919.2420.7726.4531.61
Upgrade
Buildings
1,2941,025978.89729.03724.68
Upgrade
Machinery
878.09773.611,1891,050537.75
Upgrade
Construction In Progress
1,0211,2681,1141,342820.8
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.